• Aspyra (Calabasas, California) reported that James Helms, who has been with the company for twenty four years, has been named interim CEO. This follows the resignation of Aspyra CEO, Steven Besbeck, effective Nov. 30. Aspyra makes clinical and diagnostic information solutions for the healthcare industry.
  • Suber Huang, MD, was named medical director for ophthalmology of Digital Healthcare (Wake Forest, North Carolina). Huang will provide the company expert advice and counsel regarding product development. Huang is a professor and vice chairman in the department of ophthalmology and visual sciences at University Hospitals Case Medical Center (Cleveland). Digital Healthcare specializes in retinal risk assessment for diabetes.
  • Kathleen Wiljanen has been appointed VP of managed care for Kindred Healthcare (Louisville, Kentucky). Prior to joining Kindred, Wiljanen was a strategic consultant with Humana. Kindred, through its subsidiaries, operates long-term acute care hospitals, skilled nursing centers and a contract rehabilitation services business.
  • Bozena Korczak, PhD, was named VP of drug development for PolyMedix (Radnor, Pennsylvania). Korczak was previously VP of R&D at Cytochroma. PolyMedix is an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics.